PAR •
Healthcare •
Biotechnology •
Quote as of 08/18/2026 15:29
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization10.88 mln
Float321 mln
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.86
Likely reliable
Relative Strength
97
/ 100
Top performer
Debt / Equity
134
Extremely leveraged
ROE
-232
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1998 and based in Strasbourg, Aton is a French life sciences company that supports the development of new treatments by offering a broad range of services, including early and late-stage drug development, monoclonal antibody production, and laboratory equipment manufacturing. The company also designs and produces medical devices, including a line built on Stemcis technology aimed at supporting surgeons in their work. In addition, Aton supplies human tissue for research and medical purposes.
